Back to funds

Venrock Adviser, LLC

Updated 6 days ago

Managed by Venrock Adviser, Llc • Latest filing Q3 2026

Portfolio value
$2.1B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$2B
Q1 2026$2.7B
Q2 2026$3.3B
Q3 2026$2.1B

Top holdings

34 positions as of Q3 2026

View filing
O

ORUKA THERAPEUTICS INC

Value
$345.5M
Shares
4.15M
% Port
16.79%
E

ERASCA INC

Value
$294.5M
Shares
20.09M
% Port
14.31%
S

SPYRE THERAPEUTICS INC

Value
$221.3M
Shares
2.49M
% Port
10.75%
K

KORSANA BIOSCIENCES INC

Value
$145.6M
Shares
4.55M
% Port
7.07%
S

SAVARA INC

Value
$101M
Shares
19.57M
% Port
4.91%
O

OCULAR THERAPEUTIX INC

Value
$79.4M
Shares
10.35M
% Port
3.86%
?
7.N/A

DAMORA THERAPEUTICS INC

Value
$76.7M
Shares
3.60M
% Port
3.73%
D

DIANTHUS THERAPEUTICS INC

Value
$72.4M
Shares
822.0K
% Port
3.52%
V

VIRIDIAN THERAPEUTICS INC

Value
$67.1M
Shares
3.26M
% Port
3.26%
V

VOR BIOPHARMA INC

Value
$58M
Shares
3.04M
% Port
2.82%
C

COGENT BIOSCIENCES INC

Value
$52.6M
Shares
1.64M
% Port
2.55%
A

ADLAI NORTYE GROUP LTD

Value
$51.4M
Shares
3.21M
% Port
2.50%
J

JADE BIOSCIENCES INC

Value
$45.2M
Shares
3.22M
% Port
2.20%
A

ACHIEVE LIFE SCIENCE INC

Value
$44.5M
Shares
5.50M
% Port
2.16%
M

MAZE THERAPEUTICS INC

Value
$42M
Shares
1.55M
% Port
2.04%
O

ORIC PHARMACEUTICALS INC

Value
$39.7M
Shares
2.94M
% Port
1.93%
D

DYNE THERAPEUTICS INC

Value
$35M
Shares
2.17M
% Port
1.70%
A

ADARX PHARMACEUTICALS INC

Value
$32.4M
Shares
1.63M
% Port
1.58%
C

CRESCENT BIOPHARMA INC.

Value
$31.1M
Shares
2.13M
% Port
1.51%
R

RELMADA THERAPEUTICS INC

Value
$28.1M
Shares
7.45M
% Port
1.36%

Explore